Application of CD 146 as molecular marker to diagnosis, periodization or prognosis of neuropsychiatric systemic lupus erythematosus (NPSLE)
A molecular marker and psychiatric technology, applied in the field of neuropsychiatric lupus molecular markers, can solve problems such as ambiguity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment
[0040] Example:: detection of sCD146 double-antibody sandwich ELISA
[0041] 1) Coating: Dilute the anti-CD146AA1 antibody to 2.5 μg / ml with 0.02 MPB (pH 7.25), mix thoroughly, add 50 μl per well to a 96-well microtiter plate, and overnight at 4°C.
[0042] 2) Blocking: Shake off the coating solution, control dryness, add 200 μl per well of 2% BSA-PBS into a 96-well ELISA plate, and block at 37° C. for 2 hours.
[0043] 3) Adding samples: shake off the blocking solution, wash 3 times with 0.1% Tween 20-PBS (PBST), and control to dry; add 50 μl of cerebrospinal fluid or serum samples from patients or normal people to each well, incubate at room temperature for 2 hours, wash with PBST for 5 times to wash away non-specific binding.
[0044] 4) The detection antibody biotinylated AA98 was diluted to 2 μg / ml with 2% BSA-PBS, and 50 μL per well was incubated at room temperature for 2 hours.
[0045] 5) Wash off the antibody, add streptavidin-HRP at an appropriate concentration, 50...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com